| Nov 15 |
Ensysce Biosciences Third Quarter 2024 Earnings: Beats Expectations
|
| Nov 13 |
ENSC Improves Position
|
| Nov 12 |
Ensysce Biosciences GAAP EPS of $0.07 beats by $0.24
|
| Nov 12 |
Ensysce Biosciences Reports Third Quarter 2024 Financial Results
|
| Nov 7 |
Ensysce Biosciences Receives Positive Nasdaq Listing Determination
|
| Nov 7 |
Why Lyft Shares Are Trading Higher By Over 21%; Here Are 20 Stocks Moving Premarket
|
| Oct 31 |
Why Carvana Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
|
| Oct 30 |
Why Alphabet Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
|
| Oct 23 |
Why Stride Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket
|
| Oct 8 |
Ensysce Biosciences Announces Leadership Team’s Participation in the Annual Pain Therapeutics Summit
|
